SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Trinity Medical Group Inc – ‘SB-2/A’ on 9/25/02 – EX-5

On:  Wednesday, 9/25/02, at 12:57pm ET   ·   Accession #:  910680-2-802   ·   File #:  333-99719

Previous ‘SB-2’:  ‘SB-2’ on 9/18/02   ·   Latest ‘SB-2’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/25/02  Trinity Medical Group Inc         SB-2/A                 4:324K                                   Troutman Sanders LLP

Pre-Effective Amendment to Registration of Securities by a Small-Business Issuer   —   Form SB-2
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SB-2/A      SB-2/A - 9/2002                                       93    482K 
 2: EX-4        Ex-4.20 - Amdt. #2 - Convertible Prom. Note            5     17K 
 4: EX-5        Exhibit 5.1 - Opinion                                  2     15K 
 3: EX-23       Ex-23.2 - Consent of Independent CPAs - 9/23/02        1      5K 


EX-5   —   Exhibit 5.1 – Opinion

EX-51st Page of 2TOCTopPreviousNextBottomJust 1st
 

EXHIBIT 5.1 JENKENS & GILCHRIST PARKER CHAPIN LLP AUSTIN, TEXAS (512) 499-3800 THE CHRYSLER BUILDING CHICAGO, ILLINOIS 405 LEXINGTON AVENUE (312) 425-3900 NEW YORK, NEW YORK 10174 DALLAS, TEXAS (214) 855-4500 (212) 704-6000 HOUSTON, TEXAS FACSIMILE (212) 704-6288 (713) 951-3300 LOS ANGELES, CALIFORNIA www.jenkens.com (310) 820-8800 SAN ANTONIO, TEXAS (210) 246-5000 WASHINGTON, D.C. (202) 326-1500 September 23, 2002 Trinity Medical Group USA, Inc. 30021 Tomas Street, Suite 300 Rancho Santa Margarita, CA 92688 Dear Sir or Madam: We have acted as special counsel to Trinity Medical Group, Inc., a Florida corporation (the "Company"), in connection with its filing of its registration statement on Form SB-2 (the "Registration Statement"), being filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the "Act"), relating to an offering of an aggregate of 18,414,569 shares of common stock, par value $.001 per share (the "Common Stock"), of the Company. In our capacity as counsel to the Company, we have examined originals or copies, satisfactory to us, of the Company's (i) Certificate of Incorporation, as amended, (ii) By-laws, as amended, and (iii) resolutions of the Company's board of directors. We have also reviewed such other matters of law and examined and relied upon such other corporate records, agreements, certificates and other documents as we have deemed relevant and necessary as a basis for the opinion hereinafter expressed. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and the conformity with the original documents of all documents submitted to us as copies or facsimiles. As to any facts material to such opinion, we have, to the extent that relevant facts were not independently established by us, relied on certificates of public officials and certificates of officers or other representatives of the Company. Based upon and subject to the foregoing, we are of the opinion that: a) The 7,000,000 shares of Common Stock issuable upon conversion of the promissory note, dated June 29, 2001 and amended on August 29, 2002, between the Company and RoyCap, Inc., when issued in accordance with the terms of such promissory note, will be legally issued, fully paid and non-assessable. b) The 528,592 shares of Common Stock issued to RoyCap, Inc. as a result of conversions to date on the promissory note dated June 29, 2001, are legally issued, fully paid and non-assessable.
EX-5Last Page of 2TOC1stPreviousNextBottomJust 2nd
JENKENS & GILCHRIST PARKER CHAPIN LLP Trinity Medical Group USA, Inc. September 23, 2002 Page 2 c) The 1,000,000 shares of Common Stock issuable upon the exercise of common stock purchase warrants, dated August 29, 2002, issued by the Company to RoyCap, Inc., when issued in accordance with the terms of the common stock purchase warrants, will be legally issued, fully paid and non-assessable. d) The 2,000,000 shares of Common Stock issuable upon the exercise of a common stock purchase warrant, dated May 31, 2002, issued by the Company to La Jolla Cove Investors, Inc., when issued in accordance with the terms of such common stock purchase warrant, will be legally issued, fully paid and non-assessable. e) The 15,207 shares of Common Stock issuable upon the exercise of common stock purchase warrants issued by the Company to Michael Z. Magat during the six month period ended June 30, 2002, when issued in accordance with the terms of such common stock purchase warrants, will be legally issued, fully paid and non-assessable. f) The 3,935,385 shares of Common Stock issued in accordance with the terms of the common stock unit subscription agreements (the "Unit Agreements") entered into between the Company and nineteen (19) accredited investors during May and June of 2002, are legally issued, fully paid and non-assessable. g) The 3,935,385 shares of Common Stock issuable upon the exercise of the warrants issued in accordance with the terms of the Unit Agreements entered into between the Company and nineteen (19) accredited investors during May and June of 2002, when issued in accordance with the terms of such warrants, will be legally issued, fully paid and non-assessable. We hereby consent to the use of our name under the caption "Legal Matters" in the prospectus constituting a part of the Registration Statement and to the filing of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act, the rules and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation S-B promulgated under the Act. Very truly yours, /s/ JENKENS & GILCHRIST PARKER CHAPIN LLP JENKENS & GILCHRIST PARKER CHAPIN LLP

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SB-2/A’ Filing    Date First  Last      Other Filings
Filed on:9/25/02
9/23/0212
8/29/0212
6/30/02210QSB,  10QSB/A,  NT 10-Q,  NTN 10K
5/31/022
6/29/011
 List all Filings 
Top
Filing Submission 0000910680-02-000802   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 1:56:46.1pm ET